- Lund-based medical technology company MedVasc has successfully raised €2.2 million in funding through subscriptions from existing shareholders. This financial boost will support the company’s efforts to secure FDA approval for its innovative anesthesia catheter, known as Solutio. The recent funding follows a previous financing round in May 2025, where the company raised €917,000.
- The latest capital infusion will allow MedVasc to complete the production and testing activities necessary for the Solutio catheter. With these activities nearing completion, the company is strategically positioning itself for regulatory clearance in the United States, which represents a significant milestone in its growth trajectory.
- MedVasc’s ongoing commitment to advancing its medical device technology underscores the importance of innovation in the healthcare sector. As the company continues to navigate the complexities of regulatory approval, stakeholders are optimistic about the potential impact of its catheter on patient care and anesthesia practices.
Source: Swedish Tech News